Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-20

Clinical Trial Update: Evaluation of the Effectiveness and Safety of Immunosuppressive and Biological Therapy of Atopic Dermatitis in Childhood [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating effectiveness and safety of immunosuppressive and biological therapy for atopic dermatitis in children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Medical Research Center for Children's Health, Russian Federation | Conditions: Atopic Dermatitis | Phase 4 | Status: UNKNOWN